Child and adolescent cancer patients should also be tested for germline TP53 variants if presenting with hypodiploid acute lymphoblastic leukemia (ALL), unexplained sonic hedgehog-driven medulloblastoma, or osteosarcoma of the jaw. This evidence concerns the gene TP53 and acute lymphoblastic leukemia.